Other inhibitors target the critical role of PLK4 in centriolar function and inhibit cell proliferation in melanoma cells [211], breast cancer [255], cervical carcinoma, and colon carcinoma [256,257] only to name a few. This evidence concerns the gene PLK4 and melanoma.